文献速递类风湿关节炎脊柱关节炎其他结缔组织病

风湿与肌肉骨骼疾病疲劳测量工具:测量性能系统综述

Instruments for measuring fatigue in people with rheumatic and musculoskeletal diseases: a systematic review of measurement properties.
PubMed 文献 · RMD Open · 2025-10-23

该系统综述遵循乔安娜布里格斯研究所与COSMIN指南,在风湿与肌肉骨骼疾病(RMD)患者中评估疲劳测量工具的测量性能。共纳入60项研究、27种工具,多数研究聚焦结构效度与组间信度且偏倚风险低,仅FACIT-Fatigue、SF-36活力、BRAF-MDQ、BRAF-NRS和FSS五种工具符合OMERACT认可标准。

要点

  • 60项研究评估27种疲劳工具,结构效度(54/60,90%)与组间信度(45/60,75%)评估最多。
  • 重测信度(13/60,21.7%)与反应度(14/60,23.3%)评估较少,但偏倚风险总体低。
  • 仅FACIT-Fatigue、SF-36活力、BRAF-MDQ、BRAF-NRS和FSS符合OMERACT认可标准。

核心结论

  • 该系统综述全面支持在临床与研究环境中使用若干经过充分验证的疲劳评估工具,尤其是FACIT-Fatigue、SF-36活力、BRAF-MDQ、BRAF-NRS和FSS。

研究设计与样本

  • 遵循乔安娜布里格斯研究所与COSMIN指南开展测量性能系统综述,检索Medline、Embase、CINAHL和Cochrane Library,由两名评价者独立完成偏倚风险评估、数据提取与合成,并按OMERACT标准评估工具。
  • 研究对象为患有风湿与肌肉骨骼疾病(RMD)的儿童、青少年/年轻成人及成人。
  • 从16657条记录中筛选,109篇全文审查,最终60篇符合纳入标准,评估27种工具的测量性能。

主要发现

  • 多数研究聚焦结构效度(54/60,90%)与组间信度(45/60,75%),总体偏倚风险低。
  • 重测信度(13/60,21.7%)与反应度(14/60,23.3%)评估较少,但总体偏倚风险亦低。
  • 关于临床试验区分度与有意义变化阈值的证据有限或缺失,提示这些领域需进一步研究。
  • 仅FACIT-Fatigue、SF-36活力、BRAF-MDQ、BRAF-NRS和FSS五种工具被评为有效、可靠且偏倚风险低,符合OMERACT认可标准。

关键数值与推荐

  • OMERACT认可标准:工具需被评为有效、可靠且偏倚风险低,仅FACIT-Fatigue、SF-36活力、BRAF-MDQ、BRAF-NRS和FSS满足。

临床怎么用

  • 该系统综述支持在临床与研究环境中使用FACIT-Fatigue、SF-36活力、BRAF-MDQ、BRAF-NRS和FSS评估RMD患者的疲劳。

局限性

  • 关于临床试验区分度与有意义变化阈值的证据有限或缺失,提示这些领域需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To summarise the measurement properties of instruments used to assess fatigue in people with rheumatic and musculoskeletal diseases (RMDs). METHODS: A systematic review (SR) of measurement properties was conducted in children, adolescents/young adults and adults with RMDs, following Joanna Briggs Institute and COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) guidelines. Searches were performed in Medline, Embase, CINAHL and Cochrane Library. Risk of bias assessment, data extraction and synthesis were conducted independently by two reviewers. Instruments were assessed according to Outcome Measures in Rheumatology (OMERACT) criteria. RESULTS: Out of 16 657 records, 109 articles underwent full-text review, and 60 met inclusion criteria. These studies evaluated the psychometric properties of 27 instruments. Most studies focused on construct validity (54/60, 90%) and intermethod reliability (45/60, 75%), with an overall low risk of bias. In contrast, test-retest reliability (13/60, 21.7%) and responsiveness (14/60, 23.3%) were less frequently assessed, but also with an overall low risk of bias. Evidence regarding clinical trial discrimination and thresholds of meaningful change was limited or absent, indicating the need for further research in these domains. Only five instruments-the Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue, the 36-Item Short Form Survey Instrument (SF-36) Vitality, the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ), the BRAF Numerical Rating Scales (BRAF-NRS) and the Fatigue Severity Scale (FSS)-were rated as valid, reliable and low risk of bias, fulfilling OMERACT endorsement criteria. CONCLUSIONS: This SR comprehensively supports the use of several well-validated instruments to assess fatigue, particularly FACIT-Fatigue, SF-36 Vitality, BRAF-MDQ, BRAF-NRS and FSS, in both clinical and research settings. PROSPERO REGISTRATION NUMBER: CRD42024507112.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Santos EJF, Farisogullari B, Fishpool K, et al. Instruments for measuring fatigue in people with rheumatic and musculoskeletal diseases: a systematic review of measurement properties. RMD Open. 2025. PMID: 41136223. doi:10.1136/rmdopen-2025-006079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。